# Karuna Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/karuna-labs

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.karunavr.com
- Total disclosed funding: $3M
- Latest round: Seed (Sep 10, 2019)
- Investors on record: 6

## About

Karuna Labs Inc. specializes in innovative pain relief solutions, integrating neurotechnology with personalized coaching to assist individuals with chronic pain and brain injuries in restoring functionality.Founded in 2016 in San Francisco, US, Karuna Labs Inc. focuses on providing advanced therapeutic solutions for pain management. The company raised USD 3.00 mn in Seed funding on September 10, 2019, led by Baseline Ventures with participation from Akatsuki Ventures, Anorak Ventures, Correlation Ventures, DreamIt Ventures, and Hustle Fund. Lincoln Nguyen serves as the CEO of the firm.KarunaHOME, developed by Karuna Labs, offers a comprehensive pain relief program designed specifically for individuals suffering from chronic pain and acquired brain injuries. The core offering integrates proprietary neurotechnology with personalized behavioral coaching, aimed at providing relief and restoring functionality within a 12-week timeframe. This innovative approach targets various pain types, including low back pain, shoulder pain, and neuropathic pain, effectively addressing the intricate needs of patients. The service is primarily directed at individuals seeking non-pharmacological solutions, and it has found traction in markets across the United States, as well as international jurisdictions that seek advanced therapeutic interventions. The clientele comprises patients who are often referred by healthcare providers, workers' compensation programs, and health plans, emphasizing a diverse customer base within the healthcare ecosystem.The revenue model for KarunaHOME revolves around a service-based structure, where clients engage in a structured program that involves both neurotechnology solutions and coaching sessions. Customers typically enter into subscription agreements for comprehensive access to the program, which includes ongoing support and assessment throughout the treatment duration. The pricing structure is designed to reflect the value of the integrated services, although specific pricing details are not disclosed. Revenue generation stems from direct-to-consumer transactions, facilitated through healthcare providers and partnerships with health plans and workers' compensation entities. This dual approach enhances accessibility and encourages the adoption of the company's offerings among a broad spectrum of patients seeking effective pain management solutions.Karuna Labs Inc. aims to leverage the USD 3.00 mn raised in Seed funding to expand its market reach and enhance product offerings. The company is focusing on the development of new pain relief programs that integrate additional neurotechnologies and coaching methodologies, scheduled for release in 2021. Furthermore, Karuna Labs plans to increase its presence in international markets, specifically targeting Europe and Asia by the end of 2021, to meet the rising demand for innovative pain management solutions.

## Funding rounds

- Seed, Sep 10, 2019, $3M — Correlation Ventures, Baseline Ventures, DreamIt Ventures, Anorak Ventures, Hustle Fund, Akatsuki Ventures

## Investors

- Correlation Ventures (https://capitalatlas.ai/funds/correlation-ventures) — Seed
- Baseline Ventures (https://capitalatlas.ai/funds/baseline-ventures) — Seed
- DreamIt Ventures (https://capitalatlas.ai/funds/dreamit-ventures) — Seed
- Anorak Ventures (https://capitalatlas.ai/funds/anorak-ventures) — Seed
- Hustle Fund (https://capitalatlas.ai/funds/hustle-fund) — Seed
- Akatsuki Ventures (https://capitalatlas.ai/funds/akatsuki-ventures) — Seed